Noninvasive Quantification of 2-Hydroxyglutarate in Human Gliomas with IDH1 and IDH2 Mutations.
about
IDH1 and IDH2 mutations as novel therapeutic targets: current perspectivesIn-Vivo Proton Magnetic Resonance Spectroscopy of 2-Hydroxyglutarate in Isocitrate Dehydrogenase-Mutated Gliomas: A Technical Review for NeuroradiologistsImproved localisation for 2-hydroxyglutarate detection at 3T using long-TE semi-LASERIn vivo detection of 2-hydroxyglutarate in brain tumors by optimized point-resolved spectroscopy (PRESS) at 7T.Non-invasive metabolic imaging of brain tumours in the era of precision medicine.MR Molecular Imaging of Brain Cancer Metabolism Using Hyperpolarized 13C Magnetic Resonance Spectroscopy.2-Hydroxyglutarate produced by neomorphic IDH mutations suppresses homologous recombination and induces PARP inhibitor sensitivity.Brain metabolic pattern analysis using a magnetic resonance spectra classification software in experimental stroke.Non-invasive detection of 2-hydroxyglutarate in IDH-mutated gliomas using two-dimensional localized correlation spectroscopy (2D L-COSY) at 7 Tesla.Echo-planar spectroscopic imaging with dual-readout alternated gradients (DRAG-EPSI) at 7 T: Application for 2-hydroxyglutarate imaging in glioma patients.Can magnetic resonance spectroscopy differentiate malignant and benign causes of lymphadenopathy? An in-vitro approachMagnetic Resonance Spectroscopy for Detection of 2-Hydroxyglutarate as a Biomarker for IDH Mutation in Gliomas.Application of metabolomics in sarcoma: From biomarkers to therapeutic targets.Metabolic Profiling of IDH Mutation and Malignant Progression in Infiltrating Glioma.Diagnostic value of glutamate with 2-hydroxyglutarate in magnetic resonance spectroscopy for IDH1 mutant glioma.Density-weighted concentric rings k-space trajectory for 1 H magnetic resonance spectroscopic imaging at 7 T.Comparison between Short and Long Echo Time Magnetic Resonance Spectroscopic Imaging at 3T and 7T for Evaluating Brain Metabolites in Patients with Glioma.Hippocampal MRS and subfield volumetry at 7T detects dysfunction not specific to seizure focus.Isocitrate dehydrogenase-mutant glioma: Evolving clinical and therapeutic implications.Highly specific determination of IDH status using edited in vivo magnetic resonance spectroscopy.A comparison of 2-hydroxyglutarate detection at 3 and 7 T with long-TE semi-LASER.Key clinical benefits of neuroimaging at 7T.IDH1 Mutation and World Health Organization 2016 Diagnostic Criteria for Adult Diffuse Gliomas: Advances in Surgical Strategy.MR spectroscopy for in vivo assessment of the oncometabolite 2-hydroxyglutarate and its effects on cellular metabolism in human brain gliomas at 9.4T.Pharmacodynamics of mutant-IDH1 inhibitors in glioma patients probed by in vivo 3D MRS imaging of 2-hydroxyglutarate.Metabolite-cycled density-weighted concentric rings k-space trajectory (DW-CRT) enables high-resolution 1 H magnetic resonance spectroscopic imaging at 3-Tesla.Biological Role and Therapeutic Potential of IDH Mutations in Cancer.Imaging biomarkers guided anti-angiogenic therapy for malignant gliomas
P2860
Q28066926-843322EF-DA20-4304-A59C-88CBA7A75354Q28069062-B1186988-C502-4E28-BECB-9AF3B208692DQ28829812-C0F9F589-D6E0-42F1-B659-5D1924697B09Q31060593-756847C5-5345-42C9-9430-09E47546AF10Q31115540-36C47FE9-D67B-44A8-B866-A3075F733AD5Q31137181-F838062D-8F37-46AE-BA7A-DEFB9404DF40Q33698756-0213807C-AB2B-45A4-B7DA-563BB90D6581Q36249269-73007C05-BEE0-4B20-8F97-1D87C97BA6D8Q37278758-45FCD738-8BD1-41ED-9C21-A99A134EBFBBQ38612062-DA585A89-E6F8-4622-BA94-45F48E92AB95Q38644899-97F540C2-1BC6-49B7-915F-A6F62F5E4F73Q39383501-BFEA7B14-B6B0-4115-A315-16D878C84ECBQ39426287-DDE14C26-8FFF-4127-A21F-7CE3FE719DD4Q40281311-3A86EE2E-9DD2-4880-8FFD-7D8BC7F5D56BQ42702320-1BB94435-C47C-4A6C-A328-E99EB18F9347Q46071396-B833C508-B101-49FA-B54D-A3EF4453C343Q46664688-5286433F-65E8-4C06-98A2-039E8B00E8B4Q47171896-ED9A0297-A501-4EE7-9AF7-B9A8066DD58AQ47605895-D39DFB8E-0982-46D7-86BE-5B1742346BAEQ47617473-E7988E29-8A34-4506-88F6-E44757F6DFB0Q48281579-EF5362A2-0376-4D67-A01C-566B6A96E6E1Q48428333-A1BEEDF7-9744-4A01-A6D3-A6A1D533D234Q48663479-4AD247E0-776E-457B-AA70-9F70CABC3FD2Q48838786-65DCE1B2-59B9-4C14-83D5-B184D1CC6F20Q52584624-AD8B3C18-642D-48BC-99F9-58C28E78CAF3Q55371263-31252379-6CD3-48B4-87AF-60BF54D88FD3Q55456962-D4FBBEF0-7F6B-4761-A44C-59FDFC34CDD9Q57177114-EFD01434-5C42-414F-9436-64B37C852F3A
P2860
Noninvasive Quantification of 2-Hydroxyglutarate in Human Gliomas with IDH1 and IDH2 Mutations.
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年学术文章
@wuu
2015年学术文章
@zh-cn
2015年学术文章
@zh-hans
2015年学术文章
@zh-my
2015年学术文章
@zh-sg
2015年學術文章
@yue
2015年學術文章
@zh
2015年學術文章
@zh-hant
name
Noninvasive Quantification of ...... with IDH1 and IDH2 Mutations.
@ast
Noninvasive Quantification of ...... with IDH1 and IDH2 Mutations.
@en
type
label
Noninvasive Quantification of ...... with IDH1 and IDH2 Mutations.
@ast
Noninvasive Quantification of ...... with IDH1 and IDH2 Mutations.
@en
prefLabel
Noninvasive Quantification of ...... with IDH1 and IDH2 Mutations.
@ast
Noninvasive Quantification of ...... with IDH1 and IDH2 Mutations.
@en
P2093
P2860
P50
P1433
P1476
Noninvasive Quantification of ...... s with IDH1 and IDH2 Mutations
@en
P2093
Khalid Al-Qahtani
Nick de Pennington
Olaf Ansorge
Puneet Plaha
Richard Stacey
Stuart Clare
Tom Cadoux-Hudson
P2860
P356
10.1158/0008-5472.CAN-15-0934
P407
P577
2015-12-15T00:00:00Z